Lyssikatos Joseph P sold ELVN
September 23, 2025 · Form 4 insider transaction
Lyssikatos Joseph P sold 1,500 shares of Enliven Therapeutics, Inc. at $20.03 per share, a transaction worth $30.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,500
Price
$20.03
Total value
$30.0K
InsiderLyssikatos Joseph P
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 23, 2025
Filing dateSeptember 25, 2025
Shares owned after931,688
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.; The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.